Department of Medical Sciences, Section of Clinical Bacteriology, Uppsala University, Uppsala, Sweden.
Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden; Science for Life Laboratory (SciLifeLab), Uppsala University, Uppsala, Sweden.
J Hosp Infect. 2017 Jul;96(3):256-261. doi: 10.1016/j.jhin.2017.04.017. Epub 2017 Apr 26.
Silver-based products have been marketed as an alternative to antibiotics, and their consumption has increased. Bacteria may, however, develop resistance to silver.
To study the presence of genes encoding silver resistance (silE, silP, silS) over time in three clinically important Enterobacteriaceae genera.
Using polymerase chain reaction (PCR), 752 bloodstream isolates from the years 1990-2010 were investigated. Age, gender, and ward of patients were registered, and the susceptibility to antibiotics and silver nitrate was tested. Clonality and single nucleotide polymorphism were assessed with repetitive element sequence-based PCR, multi-locus sequence typing, and whole-genome sequencing.
Genes encoding silver resistance were detected most frequently in Enterobacter spp. (48%), followed by Klebsiella spp. (41%) and Escherichia coli 4%. Phenotypical resistance to silver nitrate was found in Enterobacter (13%) and Klebsiella (3%) isolates. The lowest carriage rate of sil genes was observed in blood isolates from the neonatology ward (24%), and the highest in blood isolates from the oncology/haematology wards (66%). Presence of sil genes was observed in international high-risk clones. Sequences of the sil and pco clusters indicated that a single mutational event in the silS gene could have caused the phenotypic resistance.
Despite a restricted consumption of silver-based products in Swedish health care, silver resistance genes are widely represented in clinical isolates of Enterobacter and Klebsiella species. To avoid further selection and spread of silver-resistant bacteria with a high potential for healthcare-associated infections, the use of silver-based products needs to be controlled and the silver resistance monitored.
银基产品已作为抗生素替代品上市,其使用量有所增加。然而,细菌可能对银产生耐药性。
研究三种临床重要肠杆菌科细菌中编码银耐药性的基因(silE、silP、silS)随时间的变化情况。
采用聚合酶链反应(PCR)对 1990 年至 2010 年间的 752 株血流感染分离株进行检测。记录患者的年龄、性别和病房,检测对抗生素和硝酸银的敏感性。采用重复元件序列 PCR、多位点序列分型和全基因组测序评估克隆性和单核苷酸多态性。
编码银耐药性的基因在肠杆菌属(48%)中最常被检测到,其次是克雷伯菌属(41%)和大肠杆菌 4%。硝酸银表型耐药性见于肠杆菌属(13%)和克雷伯菌属(3%)分离株。新生儿科血培养分离株携带 sil 基因的比例最低(24%),肿瘤科/血液科血培养分离株携带 sil 基因的比例最高(66%)。国际高危克隆中存在 sil 基因。sil 和 pco 簇的序列表明,silS 基因的单个突变事件可能导致了表型耐药性。
尽管瑞典医疗保健中对银基产品的使用受到限制,但临床分离的肠杆菌和克雷伯菌属中广泛存在银耐药基因。为避免具有高医源性感染潜力的银耐药菌进一步选择和传播,需要控制银基产品的使用并监测银耐药性。